Literature DB >> 16639714

ARC protects rat cardiomyocytes against oxidative stress through inhibition of caspase-2 mediated mitochondrial pathway.

Yi-Qiang Zhang1, Brian Herman.   

Abstract

Apoptosis repressor with a CARD domain (ARC) has been demonstrated to protect heart cells against ischemia/reperfusion (I/R) injury. In this study, we investigated the mechanism by which ARC protects heart cells against oxidative stress. We monitored the extent of apoptosis and activity of multiple components of the intrinsic apoptotic pathway in rat cardiac myoblast cell line H9c2 with either reduced or increased expression of ARC during oxidative stress. Overexpression of ARC-inhibited oxidative stress-induced caspase-2/3 activation, cytochrome c release, and translocation of Bax to mitochondria. Furthermore, phosphorylation of ARC at threonine 149 was found to be critical to its function. ARC containing a T149A mutation failed to translocate to mitochondria, did not inhibit caspase-2 activation, and had a dominant negative effect against the protective effect of endogenous ARC during oxidative stress. In addition, wild-type ARC but not the T149A mutant inhibited cell death induced by overexpression of caspase-2. Using a yeast two-hybrid (YTH) screening approach and co-immunoprecipitation (Co-IP), we found that protein phosphatase 2C (PP2C) interacted with ARC and that PP2C mediated-dephosphorylation of ARC inhibited its anti-apoptotic activity. Eliminating either the N-terminal CARD domain or the C-terminal P/E domain also abolished the anti-apoptotic function of ARC, suggesting that full-length ARC is required for its apoptotic inhibition. These results indicate that ARC plays an important role in protection of H9c2 cells against oxidative stress-induced apoptosis by phosphorylation-dependent suppression of the mitochondria-mediated intrinsic pathway, partially initiated through the activation of caspase-2. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639714     DOI: 10.1002/jcb.20946

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

Authors:  Bing Z Carter; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Deborah A Thomas; Farhad Ravandi; Hagop M Kantarjian; Erich Koller; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2010-11-01       Impact factor: 22.113

2.  Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.

Authors:  P Y Mak; D H Mak; H Mu; Y Shi; P Ruvolo; V Ruvolo; R Jacamo; J K Burks; W Wei; X Huang; S M Kornblau; M Andreeff; B Z Carter
Journal:  Apoptosis       Date:  2014-04       Impact factor: 4.677

3.  Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis.

Authors:  Indrani Sinha-Hikim; Theodore C Friedman; Mark Falz; Victor Chalfant; Mohammad Kamrul Hasan; Jorge Espinoza-Derout; Desean L Lee; Carl Sims; Peter Tran; Sushil K Mahata; Amiya P Sinha-Hikim
Journal:  Cell Tissue Res       Date:  2016-12-05       Impact factor: 5.249

Review 4.  The role of caspase-2 in stress-induced apoptosis.

Authors:  Lisa Bouchier-Hayes
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310

5.  MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.

Authors:  X Li; N Du; Q Zhang; J Li; X Chen; X Liu; Y Hu; W Qin; N Shen; C Xu; Z Fang; Y Wei; R Wang; Z Du; Y Zhang; Y Lu
Journal:  Cell Death Dis       Date:  2014-10-23       Impact factor: 8.469

6.  ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.

Authors:  Tao Xu; Wei Ding; Xiang Ao; Xianming Chu; Qinggong Wan; Yu Wang; Dandan Xiao; Wanpeng Yu; Mengyang Li; Fei Yu; Jianxun Wang
Journal:  Redox Biol       Date:  2018-11-02       Impact factor: 11.799

Review 7.  MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.

Authors:  Daniel Jakubik; Alex Fitas; Ceren Eyileten; Joanna Jarosz-Popek; Anna Nowak; Pamela Czajka; Zofia Wicik; Harald Sourij; Jolanta M Siller-Matula; Salvatore De Rosa; Marek Postula
Journal:  Cardiovasc Diabetol       Date:  2021-02-27       Impact factor: 9.951

Review 8.  Pyroptosis and Its Regulation in Diabetic Cardiomyopathy.

Authors:  Yafang Lu; Yaqiong Lu; Jun Meng; Zuo Wang
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.